Hippophae Rhamnoides‐derived Phytomedicine Nano‐System Modulates Bax/Fas Pathways to Reduce Proliferation in Triple‐Negative Breast Cancer
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Jabeen Farheen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, P. R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Cell Proliferation, Hippophae, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Zhejiang International Science and Technology Cooperation Project, Jabeen Farheen acknowledges the Zhejiang Sci-Tech University Common.
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) is the most common primary tumor of the breast with limited effectual drug availability. Therefore, the aim of the study is to develop an innovative phyto‐nanomedicine (PNM) to cure TNBC with the least genotoxicity. Hereinafter, the sea buckthorn’ extracted polyphenols (SBP), combine with metformin (MET), are synthesized as a novel PNM to evaluate its anti‐tumor properties, effectiveness, and mechanism of action in TNBC in vitro and in vivo models. The SBP exhibits 16 new kinds of polyphenols that are been reported earlier which regulated cell development, proliferation, and programmed cell death (PCD) effectively. SBP‐MET PNM inhibits MDA‐MB‐231 (47%), MDA‐MB‐436 (46%), and 4T1 (46%) cell proliferation but does not affect L929 normal murine cell development and successfully induce PCD (73.19%) in MDA‐MB‐231 cells. Mechanistically, in vivo SBP‐MET proteome expression profiling reveals upregulation of proapoptotic Bax protein and activation of Fas signaling pathways convince downstream Daxx and FADD proteins, which further triggers Caspase‐3 that prompts apoptosis in human TNBC cells by cleaving PARP‐1 protein. Current findings establish innovative highly biocompatible phyto‐nanomedicine that has significant potential to inhibit TNBC cell growth and induce regulated cell death (RCD) in vivo model, thereby opening a new arena for TNBC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, P. R. China.
- Institute for Intelligent Bio/Chem Manufacturing, Zhejiang University-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, 311200, P. R. China.
ORCID-Profile: M Zubair Iqbal
Förderung
- Zhejiang International Science and Technology Cooperation Project
- Jabeen Farheen acknowledges the Zhejiang Sci-Tech University Common
Zitieren
APA
Farheen, J., Iqbal, M. Z., Mushtaq, A., Hou, Y., & Kong, X. (2024). Hippophae Rhamnoides‐derived Phytomedicine Nano‐System Modulates Bax/Fas Pathways to Reduce Proliferation in Triple‐Negative Breast Cancer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401197
Vancouver
Farheen J, Iqbal MZ, Mushtaq A, Hou Y, Kong X. Hippophae Rhamnoides‐derived Phytomedicine Nano‐System Modulates Bax/Fas Pathways to Reduce Proliferation in Triple‐Negative Breast Cancer. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401197
BibTeX
@article{Farheen2024,
author = {Farheen, Jabeen and Iqbal, M Zubair and Mushtaq, Asim and Hou, Yike and Kong, Xiangdong},
title = {Hippophae Rhamnoides‐derived Phytomedicine Nano‐System Modulates Bax/Fas Pathways to Reduce Proliferation in Triple‐Negative Breast Cancer},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401197}
}
EUVIMED